Chief Specialist on Hemophilia-HaematologyMorozovskaya Children's City Clinical HospitalMoscow, Moskva, Russia
PB0235 - Phase 3 Study of the Efficacy, Pharmacokinetics, Immunogenicity and Safety of von Willebrand Factor/Factor VIII Concentrate in Patients with Severe von Willebrand Disease under 6 Years of Age
Sunday, June 25, 202318:30 – 19:30 ET
PB0840 - Efficacy of prophylaxis with a plasma-derived von Willebrand factor/ factor VIII concentrate in patients with von Willebrand disease: Subgroup analysis by age and VWD type
Monday, June 26, 202318:30 – 19:30 ET
